Tag: Roches
Merck, Eisai’s Keytruda-Lenvima combo stonewalled in liver cancer after Roche’s first-in-class...
Tumor response data previously won Merck & Co. and partner Eisai an FDA breakthrough therapy designation for the combination of PD-1 star Keytruda and...
Roche’s Actemra falls short in Italian study in early-stage COVID-19 pneumonia
Roche’s Actemra, one of several anti-inflammatory drugs in testing against coronavirus, didn’t help patients with early-stage COVID-19 pneumonia, an Italian study found, though it...
Merck’s Keytruda flops bladder cancer trial, giving Roche’s Tecentriq an open...
Merck & Co.’s Keytruda has several clinical wins under its belt that have led to a long list of FDA approvals. But it can’t...
ASCO: Roche’s Alecensa stays on top of Xalkori with long-term survival...
Roche made a splash at ASCO three years ago with data showing that its Alecensa could top Pfizer’s Xalkori at keeping ALK-positive lung-cancer at bay....
Roche’s Kadcyla wins NICE backing in early breast cancer use
Unlike its first U.K. reimbursement negotiations, Roche’s HER2 antibody-drug conjugate sailed through a new NHS funding review that now puts it in line for...
Roche’s fast-moving Hemlibra breaks into wider hemophilia market with blockbuster approval
Roche’s Hemlibra officially has the hemophilia indication it’s been waiting for—and that its competitors have been dreading.
On Thursday, the FDA approved the drug to...
